Transient elastography: a new noninvasive diagnostic tool for assessment of chronic allograft nephropathy

[1]  L. Orlić,et al.  Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. , 2014, Medical hypotheses.

[2]  D. S̆timac,et al.  Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease Proven by Transient Elastography , 2013, Kidney and Blood Pressure Research.

[3]  G. Wong,et al.  Transient elastography: Kill two birds with one stone? , 2013, World journal of hepatology.

[4]  S. Mueller,et al.  Assessment of renal allograft fibrosis by transient elastography , 2013, Transplant international : official journal of the European Society for Organ Transplantation.

[5]  EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. , 2012, Journal of hepatology.

[6]  M. Tanter,et al.  Detection of intrarenal microstructural changes with supersonic shear wave elastography in rats , 2011, European Radiology.

[7]  S. Zeuzem,et al.  EASL Clinical Practice Guidelines: management of hepatitis C virus infection. , 2011, Journal of hepatology.

[8]  C. Loddenkemper,et al.  Noninvasive evaluation of renal allograft fibrosis by transient elastography – a pilot study , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[9]  H. Mahallati,et al.  Assessment of chronic renal allograft nephropathy using contrast-enhanced MRI: a pilot study. , 2010, AJR. American journal of roentgenology.

[10]  S. Paraskevas,et al.  Management of chronic allograft nephropathy: a systematic review. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[11]  A. Chan,et al.  Alanine aminotransferase‐based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B , 2009, Journal of viral hepatitis.

[12]  S. Milani,et al.  Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C , 2008, Gut.

[13]  D. Rush,et al.  Lack of Benefit of Early Protocol Biopsies in Renal Transplant Patients Receiving TAC and MMF: A Randomized Study , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  R. Colvin,et al.  Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’) , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  M. Merrilees,et al.  Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques , 2006, Nephrology.

[16]  J. Chapman,et al.  Chronic Allograft Nephropathy: Current Concepts and Future Directions , 2006, Transplantation.

[17]  J. Chapman,et al.  Chronic renal allograft dysfunction. , 2005, Journal of the American Society of Nephrology : JASN.

[18]  D. Goldfarb,et al.  The natural history of chronic allograft nephropathy. , 2005, The Journal of urology.

[19]  V. de Lédinghen,et al.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. , 2005, Gastroenterology.

[20]  H. Meier‐Kriesche,et al.  Poor Predictive Value of Serum Creatinine for Renal Allograft Loss , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.